Main menu

Accelerated identification of disease-causing variants with ultra-rapid nanopore genome sequencing


Abstract

Whole-genome sequencing can identify variants that cause genetic disease, but the time required for sequencing and analysis has been a barrier to its use in critical care settings. Using nanopore sequencing, we developed a pipeline that was shown to identify clinically actionable genetic variants in as little as 7 hours 18 minutes. To achieve this, we accelerated sample preparation, leveraged the full capacity of PromethION 48 sequencing, developed a bioinformatics pipeline with near real-time basecalling and alignment plus accurate variant calling, and customised variant prioritization. Here, we will discuss these optimisations in detail.

Authors: John E. Gorzynski & Sneha D. Goenka

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag